HSU; MING CHU
Patent Applications and Registrations
Patent applications and USPTO patent grants for HSU; MING CHU.The latest application filed is for "compositions for prevention or suppression of cancer or cancer relapse".
- HSU; MING CHU - HACIENDA HEIGHTS CA US
- Hsu; Ming-Chu - Santa Clara CA
- Hsu; Ming-Chu - Taipei City US
- Hsu; Ming-Chu - Glendora CA
- Hsu; Ming-Chu - Taipei TW
- Hsu; Ming-Chu - Chu-Pei TW
- Hsu; Ming-Chu - Chu-Pei City TW
- Hsu; Ming-Chu - New York NY
| Patent | Date |
|---|---|
| Compositions For Prevention Or Suppression Of Cancer Or Cancer Relapse App 20200330508 - WANG; FU NAN ; et al. | 2020-10-22 |
| Cap-dependent endonuclease inhibitors Grant 10,596,171 - Lin , et al. | 2020-03-24 |
| Trans-isomeric heterocyclic compounds and preparation thereof Grant 10,377,714 - Chou , et al. A | 2019-08-13 |
| Cap-dependent Endonuclease Inhibitors App 20190224198 - Lin; Chu-Chung ; et al. | 2019-07-25 |
| Trans-isomeric Heterocyclic Compounds And Preparation Thereof App 20190047956 - Chou; Shan-Yen ; et al. | 2019-02-14 |
| Solid dispersion formulation Grant 10,004,719 - Hsu , et al. June 26, 2 | 2018-06-26 |
| Scanner capable of executing static calibration and compensation value adjustment method therefor Grant 9,871,931 - Luo , et al. January 16, 2 | 2018-01-16 |
| Substituted pyrimidines for mobilizing cells expressing a type 4 CXC chemokine receptor Grant 9,375,406 - Hsu , et al. June 28, 2 | 2016-06-28 |
| Mobilizing Cells Expressing A Type 4 Cxc Chemokine Receptor With 4-amino Pyrimidine Compounds App 20160090394 - Hsu; Ming-Chu ; et al. | 2016-03-31 |
| Treatment of antibiotic-resistant bacteria infection Grant 8,211,909 - Hsu , et al. July 3, 2 | 2012-07-03 |
| Antibiotic Drug App 20120157492 - Hsu; Ming-Chu ; et al. | 2012-06-21 |
| Pneumonia Treatment App 20100041697 - Chiu; Kit ; et al. | 2010-02-18 |
| Methods of 1H-indol-3-yl-2-oxoacetamide compounds Grant 7,662,834 - Chen , et al. February 16, 2 | 2010-02-16 |
| Treatment Of Antibiotic-resistant Bacteria Infection App 20100004282 - Hsu; Ming-Chu ; et al. | 2010-01-07 |
| Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases Grant 7,462,594 - Yang , et al. December 9, 2 | 2008-12-09 |
| Single-cluster lamp drive device Grant 7,450,095 - Yu , et al. November 11, 2 | 2008-11-11 |
| Novel Compounds And Methods Of Use Thereof App 20080242701 - Chen; Chiung-Tong ; et al. | 2008-10-02 |
| Use of 1H-indol-3-yl-2-oxoacetamide compounds Grant 7,396,838 - Chen , et al. July 8, 2 | 2008-07-08 |
| Single-cluster lamp drive device App 20060214877 - Yu; Te-Cheng ; et al. | 2006-09-28 |
| Light emitting device single-cluster lamp control system App 20060214878 - Yu; Te-Cheng ; et al. | 2006-09-28 |
| Novel compounds and methods of use thereof App 20050234098 - Chen, Chiung-Tong ; et al. | 2005-10-20 |
| Protease inhibitors App 20050143320 - Yang, Syaulan ; et al. | 2005-06-30 |
| Indol-3-YL-2-oxoacetamide compounds and methods of use thereof Grant 6,903,104 - Chen , et al. June 7, 2 | 2005-06-07 |
| Treatment and diagnostics of cancer App 20050003405 - Chen, Hua-Chien ; et al. | 2005-01-06 |
| Imidazolidinone compounds Grant 6,706,739 - Shia , et al. March 16, 2 | 2004-03-16 |
| Novel compounds and methods of use thereof App 20030181482 - Chen, Chiung-Tong ; et al. | 2003-09-25 |
| Imidazolidinone compounds App 20030087936 - Shia, Kak-Shan ; et al. | 2003-05-08 |
| Pharmaceutical composition for the treatment of hepatocellular carcinoma App 20010018445 - Huang, Chun-Ying ; et al. | 2001-08-30 |
| Method for treating retroviral infections with aryl-(2-pyrryl) keytone compound Grant 5,164,376 - Hsu , et al. November 17, 1 | 1992-11-17 |
| Method for determining anti-viral transactivating activity Grant 5,070,010 - Hsu December 3, 1 | 1991-12-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 